Zhitong Finance App News, Tianyu Co., Ltd. (300702.SZ) issued an announcement. Zhejiang Nuode Pharmaceutical Co., Ltd. (“Nuode Pharmaceutical”), a wholly-owned subsidiary of the company, recently received a “Drug Registration Certificate” for vardenafil hydrochloride tablets approved and issued by the State Drug Administration. The indications are: treatment of male penile erectile dysfunction.

The company's product, vardenafil hydrochloride tablets, can be produced and sold domestically after receiving approval from the State Drug Administration, further enriching the company's formulation specifications, which is expected to increase the company's formulation business revenue, help enhance the market competitiveness of the company's products, and have a positive impact on the company's business performance.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.